Tanya Hayden

Chief Operating Officer presso ACER THERAPEUTICS INC.

44 anni

Health Technology

Consumer Services

Profilo

Tanya Hayden is currently the Chief Operating Officer at Acer Therapeutics, Inc. She previously worked as the Director of Operational Excellence at Lonza Group AG from 2018 to 2021 and as the Vice President of Manufacturing at Bend Research, Inc. from 2014 to 2018.
Ms. Hayden completed her undergraduate degree at Gonzaga University.

Posizioni attive di Tanya Hayden

Società	Posizione	Inizio
ACER THERAPEUTICS INC.	Chief Operating Officer	21/06/2022

Tutte le posizioni attive di Tanya Hayden

Precedenti posizioni note di Tanya Hayden

Società	Posizione	Fine
LONZA GROUP AG	Corporate Officer/Principal	01/06/2021
Bend Research, Inc. Bend Research, Inc. Pharmaceuticals: MajorHealth Technology Bend Research, Inc. provides drug delivery and formulation development technologies. The company is headquartered in Bend, OR.	Corporate Officer/Principal	01/04/2018

Vedi nel dettaglio l'esperienza di Tanya Hayden

Formazione di Tanya Hayden

Gonzaga University

Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Tanya Hayden

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
LONZA GROUP AG	Health Technology

Aziende private	2
Bend Research, Inc. Bend Research, Inc. Pharmaceuticals: MajorHealth Technology Bend Research, Inc. provides drug delivery and formulation development technologies. The company is headquartered in Bend, OR.	Health Technology
Acer Therapeutics, Inc. Acer Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Acer Therapeutics, Inc. is a pharmaceutical company, which engages in the acquisition, development, and commercialization of therapies for medical needs. Its product pipeline includes Olpruva, Edsivo, and ACER-801. Olpruva is used for the treatment of urea cycle disorders. Edsivo is a type of celiprolol used in treating Vascular Ehlers-Danlos syndrome. ACER-001 treats menopausal related Vasomotor symptoms. The company was founded by Chris Schelling on March 15, 1991 and is headquartered in Newton, MA.	Health Technology